We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$10.1B
1-Year Est. Return
42.88%
This Fund
S&P 500
This Quarter
Est. Return
+0.07%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$14.3B
AUM Growth
-$743M
(-4.9%)
Cap. Flow
-$494M
Cap. Flow
% of AUM
-3.46%
Top 10 Holdings %
Top 10 Hldgs %
8.41%
Holding
1,329
New
83
Increased
398
Reduced
492
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CORE
Core Mark Holding Co., Inc.
CORE
|
+$24M |
| 2 |
Manhattan Associates
MANH
|
+$21.1M |
| 3 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$19.9M |
| 4 |
Camping World
CWH
|
+$19.3M |
| 5 |
AL
Air Lease Corp
AL
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$35.5M |
| 2 |
Woodward
WWD
|
+$35M |
| 3 |
Copart
CPRT
|
+$22.9M |
| 4 |
BGC
General Cable Corporation
BGC
|
+$22.7M |
| 5 |
ORBK
Orbotech Ltd
ORBK
|
+$22.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 28.26% |
| 2 | Technology | 16.98% |
| 3 | Consumer Discretionary | 14.15% |
| 4 | Financials | 11.65% |
| 5 | Materials | 6.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
676
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.51M | 0.02% |
184,665
-146,300
| -44% | -$3.13M |
|
677
Carlyle Group
CG
$16.3B
| $3.5M | 0.02% |
164,000
| – | – |
|
|
CTLP
678
DELISTED
Cantaloupe
CTLP
| $3.48M | 0.02% |
386,300
+46,000
| +14% | +$411K |
|
|
SFBS
679
ServisFirst Bancshares
SFBS
$4.79B
| $3.47M | 0.02% |
85,000
| – | – |
|
680
Larimar Therapeutics
LRMR
$416M
| $3.47M | 0.02% |
38,782
-6,926
| -15% | -$587K |
|
|
NTZ
681
Natuzzi
NTZ
$15.6M
| $3.46M | 0.02% |
419,260
| – | – |
|
|
ITI
682
DELISTED
Iteris, Inc.
ITI
| $3.46M | 0.02% |
697,000
+121,000
| +21% | +$751K |
|
|
MAG
683
DELISTED
MAG Silver
MAG
| $3.44M | 0.02% |
352,950
+226,800
| +180% | +$2.47M |
|
|
TVPT
684
DELISTED
Travelport Worldwide Limited
TVPT
| $3.43M | 0.02% |
210,000
-40,000
| -16% | -$554K |
|
|
BNCL
685
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $3.41M | 0.02% |
219,540
-16,700
| -7% | -$266K |
|
686
Tactile Systems Technology
TCMD
$620M
| $3.41M | 0.02% |
107,269
+1,780
| +2% | +$55K |
|
|
ATSG
687
DELISTED
Air Transport Services Group
ATSG
| $3.4M | 0.02% |
146,000
+65,000
| +80% | +$1.59M |
|
|
VRTU
688
DELISTED
Virtusa Corporation
VRTU
| $3.4M | 0.02% |
70,093
-118,523
| -63% | -$5.65M |
|
689
FTAI Aviation
FTAI
$22.2B
| $3.39M | 0.02% |
248,952
+2,927
| +1% | +$43.1K |
|
690
Scorpio Tankers
STNG
$3.96B
| $3.39M | 0.02% |
173,032
+1,000
| +0.6% | +$25.4K |
|
691
Utah Medical Products
UTMD
$214M
| $3.37M | 0.02% |
34,073
-15
| -0% | -$1.34K |
|
692
StoneX
SNEX
$8.83B
| $3.36M | 0.02% |
399,062
+126,563
| +46% | +$1.06M |
|
693
Green Plains
GPRE
$1.19B
| $3.36M | 0.02% |
200,000
| – | – |
|
|
AVID
694
DELISTED
Avid Technology Inc
AVID
| $3.36M | 0.02% |
739,998
+105,000
| +17% | +$533K |
|
695
HubSpot
HUBS
$10.5B
| $3.36M | 0.02% |
31,000
| – | – |
|
696
Diamondrock Hospitality Co
DRH
$2.63B
| $3.34M | 0.02% |
320,000
-80,000
| -20% | -$884K |
|
|
XENT
697
DELISTED
Intersect ENT, Inc
XENT
| $3.34M | 0.02% |
85,000
-9,000
| -10% | -$329K |
|
|
FSB
698
DELISTED
Franklin Financial Network, Inc.
FSB
| $3.32M | 0.02% |
101,745
+99,999
| +5,727% | +$3.33M |
|
|
PVG
699
DELISTED
PRETIUM RESOURCES INC.
PVG
| $3.32M | 0.02% |
499,122
+30,000
| +6% | +$236K |
|
700
PDF Solutions
PDFS
$2.13B
| $3.31M | 0.02% |
284,275
-68,900
| -20% | -$916K |
|
Similar funds
GI
IIM
ACA
VPIM
RI
OIA
MG
LWCFA
Royce & Associates's Q1 2018 Portfolio in Review
As of Q1 2018, Royce & Associates held 1,329 positions worth $14.3B, down 4.9% from $15B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Royce & Associates withdrew a net $494M in Q1 2018, closing 75 positions and reducing 492 holdings. Its most notable exit was Sucampo Pharmaceuticals, Inc., an estimated $15.8M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Royce & Associates opened a new position in PotlatchDeltic worth $12M.
- Royce & Associates's largest Q1 2018 buy was PotlatchDeltic: 230,008 shares worth $12M.
- Royce & Associates added most to Core Mark Holding Co., Inc. in Q1 2018, an estimated $24M increase.
- Royce & Associates's biggest Q1 2018 reduction was MKS Inc, cutting an estimated $35.5M.
- Royce & Associates fully exited Sucampo Pharmaceuticals, Inc. in Q1 2018, selling an estimated $15.8M.
- Royce & Associates's ten largest holdings make up 8.4% of its $14.3B portfolio in Q1 2018.
- Royce & Associates opened 83 new positions and closed 75 in Q1 2018.
- Royce & Associates's portfolio value fell 4.9% quarter-over-quarter to $14.3B.
Based on Royce & Associates's 13F filing for Q1 2018, filed 14 May 2018.